Skip to main content

Table 5 Significant correlations

From: Iodine-125 seed brachytherapy for early stage prostate cancer: a single-institution review

  No. of pts. Spearmen-Rho p-value
Quality of life    
Health status 111 0.882 0.000
ICIQ (1) 111 −0.211 0.027
IPSS (2) 104 −0.204 0.037
Urethral D30 (3)    
Volume of prostate 162 −0.326 0.000
IPSS at survey    
IPSS (preimplant) 103 0.287 0.003
Seed dislocation/loss   
V100 (4) 163 −0.262 0.001
D90 (5) 163 −0.190 0.015
  1. (1) ICIQ: international consultation on incontinence modular questionnaire.
  2. (2) IPSS: international prostate symptom score.
  3. (3) D30: dose to 30% of the urethra.
  4. (4) V100: volume of the prostate receiving 100% of the prescription dose.
  5. (5) D90: dose to 90% of the prostate.